Skip to content
healthcare.dev
Get a free key

TAKHZYRO

NDC 47783-646, lanadelumab-flyo, solution, from Takeda Pharmaceuticals America, Inc..

Product NDC
47783-646
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761090
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/47783-646 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LANADELUMAB300 mg/2mL

Pharmacologic classes

Kallikrein Inhibitors [MoA]; Plasma Kallikrein Inhibitor [EPC]

Package NDCNDC-11Package
47783-646-01477830646011 SYRINGE, GLASS in 1 CARTON (47783-646-01) / 2 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/15f99d8c-efe7-4f7d-aa20-0d0f1e30c6e8

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=47783-646

Use it

Look up 47783-646 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/47783-646 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 47783-646. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.